RedHill Biopharma Ltd.
RDHL
$1.64
-$0.09-5.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.31M | -8.79M | -8.27M | -19.22M | -30.17M |
| Total Depreciation and Amortization | 369.00K | 494.00K | 619.00K | 721.00K | 823.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.21M | -1.28M | -3.77M | 3.36M | 10.49M |
| Change in Net Operating Assets | -463.00K | 795.00K | 2.05M | -1.66M | -5.37M |
| Cash from Operations | -8.20M | -8.78M | -9.37M | -16.80M | -24.23M |
| Capital Expenditure | -12.00K | -10.50K | -9.00K | -7.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 7.50K | 15.00K |
| Cash from Investing | -12.00K | -10.50K | -9.00K | 500.00 | 10.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -411.00K | -523.50K | -636.00K | -818.00K | -1.00M |
| Issuance of Common Stock | 3.45M | 5.86M | 8.26M | 12.69M | 17.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 739.00K | 764.50K | 790.00K | 4.60M | 8.40M |
| Cash from Financing | 3.78M | 6.10M | 8.42M | 16.47M | 24.53M |
| Foreign Exchange rate Adjustments | 24.00K | 16.50K | 9.00K | -8.00K | -25.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.41M | -2.68M | -952.00K | -335.50K | 281.00K |